Literature DB >> 16790577

Medication access through patient assistance programs.

Danielle Chauncey1, C Daniel Mullins, Bac V Tran, Diane McNally, Robert N McEwan.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16790577     DOI： 10.2146/ajhp050457

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  6 in total

1.  Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication.

Authors:  Walid F Gellad; Haiden A Huskamp; Angela Li; Yuting Zhang; Dana Gelb Safran; Julie M Donohue
Journal:  J Gen Intern Med       Date:  2011-07-13       Impact factor: 5.128

2.  Co-pay cards in Canada: Improving choice or institutionalizing bribes?

Authors:  Marc-André Gagnon
Journal:  CMAJ       Date:  2019-11-11       Impact factor: 8.262

Review 3.  What is the evidence for pharmaceutical patient assistance programs? A systematic review.

Authors:  Tisha M Felder; Nynikka R Palmer; Lincy S Lal; Patricia Dolan Mullen
Journal:  J Health Care Poor Underserved       Date:  2011-02

4.  [Three types of brand name loyalty strategies set up by drug manufacturers].

Authors:  Marie-Claude PréMont; Marc-André Gagnon
Journal:  Healthc Policy       Date:  2014-11

5.  Drug company-sponsored patient assistance programs: a viable safety net?

Authors:  Niteesh K Choudhry; Joy L Lee; Jessica Agnew-Blais; Colleen Corcoran; William H Shrank
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

6.  Serving underserved transplant recipients: experience of the Medication Access Program.

Authors:  Christina A Spivey; Marie A Chisholm-Burns; Charlene Garrett; Kenneth M Duke
Journal:  Patient Prefer Adherence       Date:  2014-05-02       Impact factor: 2.711
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.